Functional Modulation of Vascular Adhesion Protein-1 by a Novel Splice Variant

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kaitaniemi, Sam ^a,b   Grön, Kirsi ^a   Elovaara, Heli ^a   Salmi, Marko ^a,b   Jalkanen, Sirpa ^a,b   Elima, Kati ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); BENZYLAMINE; COMPLEMENTARY DNA; HISTIDINE; MESSENGER RNA; METHYLAMINE; VASCULAR ADHESION PROTEIN 1;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIMERIZATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; FETUS; GENETIC CONSERVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR STABILITY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RNA SPLICING; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

ADULT; ALTERNATIVE SPLICING; AMINE OXIDASE (COPPER-CONTAINING); AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BENZYLAMINES; CELL ADHESION MOLECULES; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEK293 CELLS; HUMANS; METHYLAMINES; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; PROTEIN MULTIMERIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; SUBSTRATE SPECIFICITY;

EID: 84872571917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054151     Document Type: Article

References (54)

1. Ley K, Laudanna C, Cybulsky MI, Nourshargh S, (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689.
2. Luster AD, Alon R, von Andrian UH, (2005) Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 6: 1182-1190.
3. Salmi M, Jalkanen S, (1992) A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257: 1407-1409.
4. Salmi M, Jalkanen S, (1996) Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J Exp Med 183: 569-579.
5. Salmi M, Kalimo K, Jalkanen S, (1993) Induction and function of vascular adhesion protein-1 at sites of inflammation. J Exp Med 178: 2255-2260.
6. Jaakkola K, Kaunismaki K, Tohka S, Yegutkin G, Vanttinen E, et al. (1999) Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol 155: 1953-1965.
7. Salmi M, Jalkanen S, (2001) VAP-1: an adhesin and an enzyme. Trends Immunol 22: 211-216.
8. Jaakkola K, Nikula T, Holopainen R, Vahasilta T, Matikainen MT, et al. (2000) In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol 157: 463-471.
9. Salmi M, Jalkanen S, (2005) Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 5: 760-771.
10. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, et al. (1998) Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 188: 17-27.
11. Salmi M, Yegutkin GG, Lehvonen R, Koskinen K, Salminen T, et al. (2001) A cell surface amine oxidase directly controls lymphocyte migration. Immunity 14: 265-276.
12. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M, (2000) Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183.
13. Mathys KC, Ponnampalam SN, Padival S, Nagaraj RH, (2002) Semicarbazide-sensitive amine oxidase in aortic smooth muscle cells mediates synthesis of a methylglyoxal-AGE: implications for vascular complications in diabetes. Biochem Biophys Res Commun 297: 863-869.
14. Zorzano A, Abella A, Marti L, Carpene C, Palacin M, et al. (2003) Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells. Biochim Biophys Acta 1647: 3-9.
15. Mercier N, Moldes M, El Hadri K, Feve B, (2001) Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells. Biochem J 358: 335-342.
16. Gokturk C, Nilsson J, Nordquist J, Kristensson M, Svensson K, et al. (2003) Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas. Am J Pathol 163: 1921-1928.
17. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
18. Kalsotra A, Cooper TA, (2011) Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet 12: 715-729.
19. Kanadia RN, Cepko CL, (2010) Alternative splicing produces high levels of noncoding isoforms of bHLH transcription factors during development. Genes Dev 24: 229-234.
20. Sunmonu NA, Li K, Li JY, (2011) Numerous isoforms of Fgf8 reflect its multiple roles in the developing brain. J Cell Physiol 226: 1722-1726.
21. Kim E, Goren A, Ast G, (2008) Alternative splicing: current perspectives. Bioessays 30: 38-47.
22. Rehwinkel J, Raes J, Izaurralde E, (2006) Nonsense-mediated mRNA decay: Target genes and functional diversification of effectors. Trends Biochem Sci 31: 639-646.
23. Shyu AB, Wilkinson MF, van Hoof A, (2008) Messenger RNA regulation: to translate or to degrade. Embo J 27: 471-481.
24. Zhang X, Azhar G, Huang C, Cui C, Zhong Y, et al. (2007) Alternative splicing and nonsense-mediated mRNA decay regulate gene expression of serum response factor. Gene 400: 131-139.
25. Jaffe EA, Nachman RL, Becker CG, Minick CR, (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756.
26. Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC, (1987) Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105: 983-990.
27. Irjala H, Elima K, Johansson EL, Merinen M, Kontula K, et al. (2003) The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels. Eur J Immunol 33: 815-824.
28. Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, et al. (2000) Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 102: 2262-2268.
29. Koskinen K, Vainio PJ, Smith DJ, Pihlavisto M, Yla-Herttuala S, et al. (2004) Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1). Blood 103: 3388-3395.
30. Laitinen M, Makinen K, Manninen H, Matsi P, Kossila M, et al. (1998) Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 9: 1481-1486.
31. Chirgwin J, Przybyla A, MacDonald R, Rutter W, (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
32. Junttila TT, Laato M, Vahlberg T, Soderstrom KO, Visakorpi T, et al. (2003) Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Clin Cancer Res 9: 5346-5357.
33. Kaitaniemi S, Elovaara H, Gron K, Kidron H, Liukkonen J, et al. (2009) The unique substrate specificity of human AOC2, a semicarbazide-sensitive amine oxidase. Cell Mol Life Sci 66: 2743-2757.
34. Tapon N, Nagata K, Lamarche N, Hall A, (1998) A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways. Embo J 17: 1395-1404.
35. Airenne TT, Nymalm Y, Kidron H, Smith DJ, Pihlavisto M, et al. (2005) Crystal structure of the human vascular adhesion protein-1: unique structural features with functional implications. Protein Sci 14: 1964-1974.
36. Ernberg K, McGrath AP, Peat TS, Adams TE, Xiao X, et al. (2010) A new crystal form of human vascular adhesion protein 1. Acta Crystallogr Sect F Struct Biol Cryst Commun 66: 1572-1578.
37. Elovaara H, Kidron H, Parkash V, Nymalm Y, Bligt E, et al. (2011) Identification of two imidazole binding sites and key residues for substrate specificity in human primary amine oxidase AOC3. Biochemistry 50: 5507-5520.
38. Matsunami H, Okajima T, Hirota S, Yamaguchi H, Hori H, et al. (2004) Chemical rescue of a site-specific mutant of bacterial copper amine oxidase for generation of the topa quinone cofactor. Biochemistry 43: 2178-2187.
39. Salmi M, Hellman J, Jalkanen S, (1998) The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes. J Immunol 160: 5629-5636.
40. Conti E, Izaurralde E, (2005) Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. Curr Opin Cell Biol 17: 316-325.
41. Chang YF, Imam JS, Wilkinson MF, (2007) The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 76: 51-74.
42. Nagy E, Maquat LE, (1998) A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 23: 198-199.
43. Harada N, Yamada Y, Tsukiyama K, Yamada C, Nakamura Y, et al. (2008) A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice. Am J Physiol Endocrinol Metab 294: E61-68.
44. Sztainberg Y, Kuperman Y, Issler O, Gil S, Vaughan J, et al. (2009) A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. Faseb J 23: 2186-2196.
45. Zarei MM, Zhu N, Alioua A, Eghbali M, Stefani E, et al. (2001) A novel MaxiK splice variant exhibits dominant-negative properties for surface expression. J Biol Chem 276: 16232-16239.
46. Belaguli NS, Zhou W, Trinh TH, Majesky MW, Schwartz RJ, (1999) Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets. Mol Cell Biol 19: 4582-4591.
47. Davies JQ, Chang GW, Yona S, Gordon S, Stacey M, et al. (2007) The role of receptor oligomerization in modulating the expression and function of leukocyte adhesion-G protein-coupled receptors. J Biol Chem 282: 27343-27353.
48. Lorenz M, Hewing B, Hui J, Zepp A, Baumann G, et al. (2007) Alternative splicing in intron 13 of the human eNOS gene: a potential mechanism for regulating eNOS activity. Faseb J 21: 1556-1564.
49. McElvaine AT, Mayo KE, (2006) A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding. Endocrinology 147: 1884-1894.
50. Gomes AR, Ferreira JS, Paternain AV, Lerma J, Duarte CB, et al. (2008) Characterization of alternatively spliced isoforms of AMPA receptor subunits encoding truncated receptors. Mol Cell Neurosci 37: 323-334.
51. Kino T, Su YA, Chrousos GP, (2009) Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci 66: 3435-3448.
52. van der Vaart M, Schaaf MJ, (2009) Naturally occurring C-terminal splice variants of nuclear receptors. Nucl Recept Signal 7: e007.
53. van Rijn RM, van Marle A, Chazot PL, Langemeijer E, Qin Y, et al. (2008) Cloning and characterization of dominant negative splice variants of the human histamine H4 receptor. Biochem J 414: 121-131.
54. de Lano W (2002) The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, CA, USA. Available: http://www.pymol.org. Accessed 2012 Dec 21.